Speech-Language Pathologists in Niles, OH Accepting Medicare

47 Speech-Language Pathologists found. Showing 21 - 40

Acacia Parsons, SLP-CONDITIONAL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606

Emily Logue, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 918 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-1606    Fax: 330-505-2621

Lisa Semenovich, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 918 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-1606

Amy Nypaver Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-207-2053

Anita Beaumont, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606

Amy Sutton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 Rhodes Rd, Niles, OH 44446 Phone: 330-505-1606    Fax: 330-505-1606

Alexa French Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800

Mrs. Jane Zador, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800

Melissa Smith Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800

Sarah L Hawout Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800

Jane Rowlands, SLP MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 918 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-1606

Abigail Fleeson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606    Fax: 330-423-4555

Mrs. Arianne Marlene Wilden, M.A. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2565 Niles Vienna Rd, Niles, OH 44446 Phone: 330-652-2053

Renee Seltzer, MSCF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606

Laura Clair Davanzo Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800

Gianna Marie Grasso, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800

Nicole Giuliano Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-505-2800

Dina M Notareschi, MA, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606    Fax: 330-423-4555

Elizabeth Weiser Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6000 Youngstown Warren Rd, Niles, OH 44446 Phone: 216-409-4785

Ashley C Shetter, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 Youngstown Warren Rd Ste A, Niles, OH 44446 Phone: 330-505-1606

News Archive

FDA approves APP Pharmaceuticals' Idarubicin HCI injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.

Mitigating challenges encountered by individuals with ASD in COVID-19 era

The COVID-19 pandemic is stressful enough, but for children and adults with autism spectrum disorder (ASD) and their families, the crisis can be especially difficult.

MedPAC offers possible offsets for Medicare physician pay fix

Still, Obama's deficit-reduction plan, released yesterday, includes no funding for the doc fix. Some are eyeing a Medicaid adjustment that will garner $13 billion in savings as a possible cash cow - but competition is stiff for these funds.

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo International plc announced today that affiliates of the company have completed the acquisition of worldwide rights to Sumavel® DosePro® (sumatriptan injection), a needle-free delivery system for subcutaneous use, from Zogenix, Inc, for $85 million in cash and rights to additional cash payments based on the achievement of certain commercial milestones.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)
• 3